<DOC>
	<DOCNO>NCT01155752</DOCNO>
	<brief_summary>The hypothesis intranasal use Pulmozyme decrease severity sinusitis Cystic Fibrosis lead improve quality life .</brief_summary>
	<brief_title>Pulmozyme Cystic Fibrosis With Sinusitis</brief_title>
	<detailed_description>The study prospective enrollment patient CF rhinosinusitis double-blind crossover study nasal nebulized DNASE versus saline . Nebulization accomplish PARI SinuStar nasal aerosol system nebulizer set power air compressor . This pilot study subject serve control . Each arm study 3 month randomization active drug versus placebo generate without knowledge subject researcher . A health care provider involve care subject responsible medication distribution randomization scheme . A daily diary collect data analysis . Visits arrange every 4 week time drug dispense , adherence daily diary compliance medication assess . At visit SF-12 , SNOT-20 , Epworth Sleepiness Scale , Rhinitis Severity Scale , Nocturnal Rhinoconjunctivitis Quality Life Specific Questionnaire ( NRQLQ ) , Cystic Fibrosis Questionnaire-Revised , Rhinosinusitis Quality Life Survey utilized acquisition data ( 17-23 ) . In addition , Physician Global Assessment self administer patient rhinosinusitis VAS score ( 0-100 100 full recovery 0 effect ) complete visit . To obtain objective data patient nasal endoscopic assessment 4 different time point nasal polyp sinusitis rat scale define Lund Kennedy Ann Otol Laryngol 1995 ; 104 ( suppl 167 ) :17-21 . ( 24 ) Serial sinus CT scan avoided decrease irradiation risk . Subjects : A total 12 patient enrol pilot study , recruitment Cystic Fibrosis Center Penn State University , IRB approval . All subject must age 15 year ( age investigator consider necessary understand consent questionnaire require study ) , either gender ethnicity . Subjects able continue presently use nasal respiratory medication long present therapeutic regimen use one month prior enrollment therapy use stable dose , method distribution without adverse event</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Sinusitis</mesh_term>
	<criteria>1 . Patients CF , age &gt; 15yo 2 . Chronic sinusitis symptom 3 . VAS score least 60 ( 0 100 ) reflect symptom associate rhinosinusitis 4 . CT scan demonstrating noncomplicated sinusitis ( define rhinosinusitis without orbit perforation , osteomyelitis , perisinus cellulitis , meningitis ) 1 . No evidence sinusitis 2 . VAS score rhinosinusitis le 60 scale 0 100 3 . Complicated sinusitis ( defined orbit perforation , osteomyelitis , perisinus cellulitis , meningitis complicate sinusitis ) 4 . Prior adverse event allergy DNASE 5 . Unwilling sign approve IRB consent 6 . Immediate indication sinus surgery 7 . Inability adhere therapy understand complete questionnaire . 8 . Being pregnant exclude subject participate subject request take birth control method actively engage sex . Further , subject request inform investigator become pregnant . Pregnancy test perform screen . 9 . Active nursing infant exclusion .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>sinusitis</keyword>
	<keyword>cystic fibrosis</keyword>
	<keyword>therapy</keyword>
</DOC>